Neuronal protein gene product 9.5 (IEF SSP 6104) is expressed in cultured human MRC-5 fibroblasts of normal origin and is strongly down-regulated in their SV40 transformed counterparts  by Honoré, Bent et al.
Vohtm¢ ..,l,iO. i~uml.~cr 2; .~):i~24o I~E|]S ~49~ 
,,t DONI~ vial 4$~)~t I~ l~=Y 
Mard~ 1~91 
Neuronal protein gone product 9.5 fIEF SSP 6104) is expressed in
cultured human MRC-5 fibroblasts of normal origin and is strongly 
down-regulated in their SV40 transformed counterparts 
Bent Honor/9. Elann¢ H. Rasmussen t';', Jo~l Vandekerckhovd and Julio E. ~elis ~ 
htatitut¢ a f  Medt¢~,,t Bioehem/xtrr and Centre for Hmnan Genuine Re, torch, darhu:t {hffver~tO'. 0/~ Warm,~ d/lb. BuihL 170. 
DK.~tO00 Aarhtv C. Demnurk and ~ Labm'ata O" of  Genrli¢~, Stale U~ffver:do" Grnt, B.90tltl Gent. l~¢llltma 
Received 20 Dewmher 1990 
Neuronal protein ~no produ~! ~L$ (P(3 P 9,5] n~olt likely identical to uhiquitin ,~arboxyl. terminal hydrola,,e i~t~'me L I (UCH.LI) has been reported 
to b¢ ~xpr¢~¢d aln~o'~t cx,~lu~tively i,~neuronal und neuro,endoerino ti~stnt~t, Ity two.diraen~ional t2D) immunobloltin[t, ¢omlgraliOn and microbe. 
¢lU~n¢inlt o( protein~t re~:ov~re~l from 2D [~1~ we have identified PGP 9,$/UCH.LI a~ polypcptid¢ IEF $SP 6104 (M,~27000. pl ~ ~,49) m the 
comprehensive 2 D Bel ¢~llula r prot,~in dalaha~ of human emhryonal tuns M RC.$ fibrobla~ts [( 19It9} I~1¢¢1 rophore~is 10. ?6~d 15; (1990) Eleetropho. 
re~i~ I I, 10"/2~. I I I :t}, Th~ protein i~ ~xpre~ed at hitlh l~vel~ in ¢lUie~eent attd prolif~ratin$ ~:ult ur~d normal fibrobla~t~ and i~ ~tronlll)* down.resuhtted 
(about 10 tim¢~) in their transformed counterparl~. 
Normal human fibrobla~t: $V40 traad'onned human lihrobl~st; PGP 9.5: UC}[-LI: Transformation senti|ire protein: 2D.gel electrophoresi~ 
1. INTRODUCTION 
Two-dimensional gel electrophoresis is a powerful 
and widely used technique for separating the protein 
constituents of cultured ceils or tissues [1,2], In this way 
the 26 kDa protein gone product 9.5 (PGP 9.5) was 
found in human brain {3] in concentrations at least 20 
times greater than in any other organ analyzed so far 
[3,4]. lmmunopcroxidasc labelling using rabbit anti- 
human PGP 9.5 serum further indicated that the ex- 
pression of this L)rotein is confined to neuronal and 
neuroendocrine tissue [5]. The primary structure of the 
protein has recently been obtained from amino acid se. 
quencing of 50°70 of the protein and by sequencing a 
eDNA isolated from a human retinal ibrary [6], Most 
recently, the structure of the gone spanning 10 kb has 
been determined [7]. 
To date, studies of the expression of this protein have 
so far been perforrned on tissues and have not included 
cultured cells. By 2D immunoblotting, comigration and 
microsequencing of proteins recovered from 2D gels we 
have identified PGP 9.5 as polypeptide IEF SSP 6104 
(Mr = 27 000, pl = 5.49) in the comprehensive 2D gel 
cellular protein database of human embryonal lung 
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Abbreviations: 2D, two.dimensional; IEF, isoelectric focusing; SSP, 
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MRC-5 fibroblasts [8,9]. We show that this protein is 
expressed at high levels in quiescent and proliferating 
cultut'ed normal fibroblasts and that it is strongly 
down-rcgulated in their SV40 transformed counter. 
parts. The implications of our results are discussed in 
view of the recent finding that this protein may corres. 
pond to ubiquitin carboxyl-terrninal hydrolase isozymc 
LI (UCH-LI) [10]. 
2, MATERIALS AND METHODS 
2,1, Cultured cells a.d tissues 
No rmal (MRC-5) and SV40 transformed human M RC-5 fibroblasts 
(MRC-5 V2) [11] and normal and SV40 transformed keratinocytes 
(KI4) [I 2j were grown as monolayer culttlres in Dutbecco's modified 
Eagle's medium containing 10o70 (v/v) fetal calf serum and antibiotics 
(penicillit~ al i00 units/ml and strepton~ycin at 50 i(g/ml), The brain 
was dissected fron~ a 4.month nor|l~al I unmtl male fetus and used as 
a source for protein microseque~tcing. Tllese experiments have been 
approved by the Ethical Scientific Committee of the Aarhus Amt- 
skom m u he, 
2.2. Labelling of cells with [J'~Sjmethionine 
Cells grown in microtlter wells (NUNC, Denmark) were labelled for 
14 I1 witl~ 0.1 ml of laboratory-made Dulbecco's modified Eagle's 
mediun~ (1 g/l, NaHCO.0 lackiLlg methionine and containing 10% 
dialyzed fetal calf serum and 100 ~Ci of ['~sS]methionine (SJ204, 
An'lershaIn) [131. 
2.3. 2D gels', immunohlotting, immuv~ofluorescetlce and silver 
staining 
The procedures for running 2D gets, i~mufi0blotfing, irn- 
munofluorescence, and silver staining I~ave been previously described 
in detail 113-15], Rabbit anti-human PGP 9.5 antiserum (RA95101) 
was obtained from UltraClone Ltd, UK. 
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Fig, 1. Two-dimensional gel images (IEF) of polypcptides from pairs of normal and SV40 transformed cultured cells, (a, b) Fluorograms of 
[35S]methionine labelled polypelgtides from MRC-5 (a) and MRC-5 V2 (b) fibroblasts, (c,d) Silver staining of MRC-5 (c) and MR.C-5 V2 (d) pro- 
teins, (e, f) Fluorograms of [3'~S]methionine labelled polypeptides from normal (e) and SV40 transformed (f) keratinocytes (I~14), Only fractions 
of tl~e gels are shown, 
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Vt~lum~ 2ttO, numbw ~ Ft~B~ I, ETTER~, ~I~i~¢I~ lr~91 
lll~ I '~i lm¢ll~i~ml~ bdled ¢,'~II~i~I ¢~t human %IRI:',~ l'ibl~bl~id~ ' il~, 
l¢ilI ~p~I wit~ illl rr~llt ,'t Itlllllb¢l ~f [¢~I'= tlnd ~llbj¢itlil Ii:~ l~rli~ll ~tl1:~ill¢ 
~,¢hl ~t¢¢tu~lltIltlt ~ p i t t  i~t;~ly de~l' ibed ! I8- I111~ The ~¢~lu,m<o w~r¢ 
J, RESULT~ 
Fii~, I shows the [~Slmethionine.labellcd protein 2D 
~el pattern (lEt;') or normal human MRC.$ ribroblaxts 
(Fi~, la) and their SV40 tran~l'ormed counterparts, 
MRC-5 V2 (Fi~. ib), Protein IEF SSP 6104 (,~I~ 
2? 000. pl = S,49)is synthesi;~d in substantial n~ounts 
by cultured normal fibroblast.~ (Fil~, la) and i t  is 
relatively abundant as estimated by silver staininlA (Fi/d, 
It), In contrast to the majority of other cellular NIRC-5 
polypeptides [9], the level or IEF SSP 6104 is down- 
resulated tO times in the transformed cells relative to 
proliferatin8 normal fibroblasts as determined by direct 
counting of the radioactivity contained in the spots 
(ratio MRC-S V2/MRC-S proliferatintd = 0.1), Normal 
quiescent and proliferatins fibroblasts express this pro- 
tein at approximately the same level (results not shown) 
[91. 
2D gel analysis or proteins of other cultured cells of 
trcm,~rormed t~riltin Stl~h Its HeI-,tI lind tr~n,~formed 
Imm an amnion ¢¢11~ (AMA)  ;tl,~o ~howed e,'<tr~mely low 
!¢v¢1~ t~r ¢,~pr¢,~sion or IEF ~SP 6104 {8,1~I. Thi~, 
however, i~ not a ~!eretal p¢~ttern for transformed tells. 
~tnee substantial level~ are found in $V40 transformed 
keratino~;yt¢~ (El4, Fil~, If}, while nor~ml keratino~;ytes 
dO not ~ynthe~l~e ~qimiricant levels of thi~ protein (Fi~,. 
le), X~to¢lcrt~m pil~tncnt~:sum cultured fibrobla~ls 
(XP2.SRO) [8] as well a~ cu tured Fetal t'ibroblasl~ from 
~kin. ear, meninl~c~ and kidney (not shown}also expre~ 
thi,~ protein at m~rked levels, 
Coml~ratiou of [S"Slmethionine labelled proteins 
from proliferatinl~ MRC.5 ribroblasts with protein ex- 
tracts from fetal luiman brain indicated that this pro- 
tein wax very abundant in the brain (result~ not ~hown). 
To assess its identity several Coom~tssie briliant blue 
spots recovered from 2D f~els of brain extract.~ were sub- 
jecte¢l to microsequencinl3 [16=181, The protein wax 
di~destetl with trypsin and peptides wet separated by 
reversed.phas~ H PLC. Six peptides were analyzed: p p-
tide 1, LGVAGQ; peptide 2. VYFMK; peptide 3, 
QTIGNSXG; peptide 4, LGFEDGSVLK; peptide 5, 
QFESETEI¢. and peptide 6, NEAIQAAHDAVA- 
QEGQ, The sequences or these peptides matche~ 
perfectly with the sequence reported for the human pro- 
tein ~.ene product 9,5 (PGP 9.5): peptide I, residues 
20-25; peptide 2, residues 79-83; peptide ~, residues 
84-91; peptide 4, residues 106-115; peptide 5, residues 
IEF , I . - -db .  I EF - - - - - -~-  MWxlO °3 
f . . . . . .  
, I  
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Fig 2, 2D immunoblotting or MRC-5 pr,:~t,.'ins reacted with ?GP 9.5 antibodies. (A) 2D immanoblotting. (B)Fluorogram used to localize the reac- 
ting spot. 
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116=i23 and peptid¢ 6, residue~ 136=!~! a~ r¢~;¢nlly 
reported by Day et al, [71. 
Further evidence indic~tting float IEF" SSP 6104 col  
responds to PGP 9.5 wax obtained by 2rt immunoblof 
tlntl of MRC-:~ protein~ using rabbit polyclonal an- 
tibodies raised against PGP 9,~ (RA 9~101, UitraCIone 
Lid. UK). As shown in Fig, 2, tire antibodies react 
strongly with a 27 kDa protein (Fi=, 2A) that col  
responds to IEF SSP 6104 as judged by superimposin~ 
tl~e X-ray fluorogram (Fill. 2B), Tl~e protein apparently 
consists of at least three charge variants. As judged by 
one.dimensional immunoblotting IEF SSP 6104/PGP 
9,5 was barely detected in the transformed cells (com- 
pare Fig. 3A and B). Indirect immunofluorescence or 
methanol-fixed normal proliferating (Fig, 4a) and SV40 
transformed fibroblasts (Fig, 4b) further confirmed the 
restllts obtained by imrnunoblotting as only MRC.5 
cells reacted strongly with the antibodies, The reason 
for the Golgi staining observed in the transformed cells 
(Fig, 4b) is most likely due to cross-reacting proteins 
(arrows in Figs 2 and 3), 
4, DISCUSSION 
Protein IEF $$P 6104 (M) ~ 27 000, p! ~ :L49) 
recorded in the ¢ompreltenfive two.dim~n)ional gel 
protein databale of cellular p rot~in.~ in human MRC-~ 
fibroblasts [9] wa.~ identified a~ protein ~ene produce 
9.5 (PGP 9,$) [631, The id~ntification was done by 
mi~rosequencing of reversed-phas~ HPLC.purffied 
tryptic peptidos, We have sequenced six peptides 
amounting to 52 of the 223 amino acid~ reported to con- 
stitute the protein 17], The six pcptides were round to 
mat~:h perfectly with internal sequences in POP 9.~. 
The identification was confirmed by 2D immunoblof 
tin~ showin~ tl~at polyclonal antibodies rai~ed against 
PGP 9,5 react strongly with IEF SSP 6104. The 
presence of this protein in cultured normal fibroblasts, 
however, is somewha~ surprising since PGP 9,5 has 
been reported to be a specific marker for neuronal and 
neuroendo¢:rine tissue [5,19] and antibodies against he 
protein have been used in a number of immunochemical 
studies to stain tumours o)' neuronal and neuroen- 
docrine origin [20-22] and innervation of organs 
[23=26], One possible xplanation t'or this discrepancy 
could be that tl~e protein is down-regulated in 
fibroblasts in their normal environment invivo and that 
culturing might induce its expression. We have largely 
confirmed the findings of Thompson et al. [51 that PGP 
6104"~ i 
+ 
A B 
Fig, 3. one.dimensional blotsof MRC-5 (A) and MRC-5 V2 proteins 
(B) reacted with PGP 9,5 antibodies. Proteins that cross-react with 
the anti bodies are indicated with arrows, 
Fig. 4. Indirect immunofluorescence of metlmnol fixed normal (a) 
and SV40 transformed MRC-5 fibroblasts {b) reacted with PGP 9.5 
antibodies, 
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9,~/IEF SSP 6104 l,t expressed in hlsh amounts In 
neuronal tiSStle whereas the expression in most other 
tis~ue~ i~ low to llndete~:table (results not ~hown). 
From bovine ,~alr thymus a family or enzymes with 
uhiqultin carboxyl-terminal hydrolytic aclivily (en- 
zymes I~ydroly~in~ small molecule adduets of ubiquitin) 
have been i~olaled and defined lately [271, Recent 
studies show that POP 9.511EF $SP 6104 belon|s to 
this family of ubiquitin earboxyl-terminal hydrolases 
(UCH) based on measurements or the enzymatic aCtiLVi" 
ty Of purified bovine PGP 9.5 [10]. It is most likely that 
PGP 9.$/ IEF SSP 6104 corresponds to ubiquitin 
earboxyl.terminat hydrolase isozyme LI (UCH-L I}  
[10]. This is based on the similar physical and kinetic 
properties of the two proteins, UCH.LI and PGP 9,5. 
Furthermore, the amino acid sequences of a number of 
parified cryptic peptides from bovine UCH-L I  and 
bovine POP 9.$ are identical with the deduced amino 
acid sequence obtained from the eDNA sequence of 
human PGP 9.5 [10b 
Ubiquitin is involved in a large variety of cellular pro. 
cesses [28,29]. The main one is likely to be the covalent 
attachment of several ubiquitin molecules to proteins 
thereby commitdnR the conjugates to be degraded by 
specific proteases which release peptides and regenerate 
ubiquitin [29]. Other functions include the connection 
of a single ubiquitin molecule to histone molecules [301 
probably playing a role in chromatin structure and gene 
expression [31]. Ubiquitin is also used to covalently 
modify receptors such as the T iymphocyte homing 
receptor [32], the platelet-derived growth factor recep- 
tor [3S] and the growth hormone receptor [341. 
The function of UCHs is unknown but may involve 
some of the above-mentioned processes, e,g. regulation 
of the specificity of the ubiquitin-dependent proteolysis 
system, control of gene transcription and cell cycle, 
regulation of the stress response, posttranslational pro- 
cessing of newly synthesized polyubiquitin and ubi. 
quitin fusion proteins [27] and modification of receptor 
function [29]. Changes in the level of expression of 
PGP 9.5/IEF SSP 6104 (most likely identical to UCH- 
Ll) in cells under various conditions, e.g. induced ex- 
pression by culturing, down-regulated expression by 
SV40 transformation or otherwise, may thus affect a 
variety of functions in the cell. 
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